Dr. Matthew Jordan Steadmon, MD

Dr. Steadmon practices at Ocala Dermatology & Skin Cancer Center, P.A. in Ocala, Florida.

Dr. Steadmon's NPI, 1104137793, was assigned on June 29, 2010. Dr. Steadmon graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2010. Dr. Steadmon holds Florida license ME116547.

Dr. Steadmon's primary practice is Ocala Dermatology & Skin Cancer Center, P.A., at 3233 Sw 33rd Rd, Ocala, FL 34474 in Marion County. The practice phone is (352) 237-2322.

Dr. Steadmon's primary practice is Ocala Dermatology & Skin Cancer Center, P.A. in Ocala, Florida. The medical group on file is Ocala Dermatology and Skin Cancer Center. Dmand AI also links Dr. Steadmon to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steadmon practices. Vendor and product names are available with a free account.

Dermatology is Dr. Steadmon's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Steadmon is board certified in dermatology by the American Board of Dermatology. Dr. Steadmon is licensed in Florida.

CMS data shows 3,996 Medicare services from Dr. Steadmon across 30 procedure codes in 2024, for 1,110 Medicare patients. Medicare paid $602,934 for them. Every service was in an office.

CMS counts 1,110 Medicare patients who saw Dr. Steadmon in 2024. The largest group is 75 to 84, with 520 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Steadmon's median patient age at 79, with 42% women.

In 2024, Dr. Steadmon wrote 586 Medicare Part D claims for 318 patients. 97% of them were for generic drugs. CMS names the drug for 486 of them, across 15 drugs with 11 or more claims each, at $10,779 in total drug cost. In 2023, CMS named 417 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Steadmon for performance year 2024, reported as part of a group. Dr. Steadmon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 780 procedures of removal of skin lesions by Dr. Steadmon, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Steadmon, published from 2013 to 2022. Dr. Steadmon's most frequent co-author is Kathryn B. Holloway, MD.

CMS Open Payments shows 92 general payments to Dr. Steadmon from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sun Pharmaceutical Industries Inc. paid the most, $457.

Dr. Steadmon graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2010.

Dr. Steadmon is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.